Company Overview of TowerBrook Capital Partners L.P.
TowerBrook Capital Partners L.P. is an investment firm specializing in direct and fund of funds investments. Within direct, it specializes in investments in growth capital, leveraged buy-outs, leveraged build-ups, and distressed situations financing in middle market companies. It does not consider investing in armaments, tobacco, sexual exploitation, and unregulated gambling. The firm seeks to invest in the consumer, air travel, transportation, industrials, logistics, restaurant, specialty finance, media, utilities, energy, chemicals, healthcare products and services, telecommunication services, and business and financial services sectors. It typically invests in European and North American ...
Park Avenue Tower
65 East 55th Street
New York, NY 10022
Founded in 2001
Key Executives for TowerBrook Capital Partners L.P.
Founder, Co-Chief Executive Officer, Co-Chairman of the Management Committee, Member of the Portfolio Committee, Member of the Executive Committee, Member of the Board of Directors, and Co-Chairman of Investment Committee
Founder, Co-Chief Executive Officer, Co-Chairman of Investment Committee, Co-Chairman of the Management Committee, Co-Chairman of Portfolio Committee, Co-Chairman of Executive Committee, and Member of the Board of Directors
Managing Director, Chief Financial Officer, Member of Executive Committee, and Member of Board of Directors
Senior Managing Director, Chief Operating Officer, General Counsel, Member of the Investment Committee, Member of Executive Committee, and Member of Board of Directors, Member of Management Committee
Senior Managing Director, Member of Investment Committee, Member of Portfolio Committee, Member of Executive Committee, Member of Risk Committee, and Member of Board of Directors, Member of Management Committee
Compensation as of Fiscal Year 2016.
TowerBrook Capital Partners L.P. Key Developments
TriMedx Seeks Acquisitions
Apr 12 16
TriMedx, LLC is seeking acquisitions. TowerBrook Capital Partners L.P. and Ascension Health Alliance, Missouri have agreed to make significant capital commitments to further invest in TriMedx to fund potential acquisitions and other growth initiatives.
J. Jill Reportedly Mulls IPO
Apr 8 16
The J. Jill Group, Inc. intends to launch an initial public offering (IPO). J. Jill has tapped Bank of America, Morgan Stanley and Jefferies Group LLC as underwriters for a possible IPO, a source familiar with the matter said. TowerBrook Capital Partners L.P. will sell its stake in the IPO. TowerBrook could seek to sell about $150 million of J. Jill shares at a valuation of $750 million to $800 million, one of the people said. An IPO is likely a better option for J. Jill than an outright sale as there are few corporate buyers with the appetite and wherewithal to pull off a purchase of the company, several people said.
TowerBrook Capital Partners L.P. Presents at Crowe Horwath Private Equity International (PEI) CFO & COO Forum, Jan-27-2016 through Jan-28-2016
Jan 24 16
TowerBrook Capital Partners L.P. Presents at Crowe Horwath Private Equity International (PEI) CFO & COO Forum, Jan-27-2016 through Jan-28-2016. Venue: The Plaza Hotel (3rd Floor Grand Ballroom Foyer and Centennial Room), Fifth Avenue at Central Park South, New York, NY 10019, United States. Presentation Date & Speakers: Jan-27-2016, Jennifer Ternoey Glassman, Managing Director, Chief Financial Officer, Member of Executive Committee, and Member of Board of Directors. Jan-28-2016, Abrielle Rosenthal, Senior Principal and Senior Compliance Counsel.
Similar Private Companies By Industry
Recent Private Companies Transactions